372 related articles for article (PubMed ID: 28281240)
1. Translational Challenges in Cardiovascular Tissue Engineering.
Emmert MY; Fioretta ES; Hoerstrup SP
J Cardiovasc Transl Res; 2017 Apr; 10(2):139-149. PubMed ID: 28281240
[TBL] [Abstract][Full Text] [Related]
2. Combining tissue repair and tissue engineering; bioactivating implantable cell-free vascular scaffolds.
Muylaert DE; Fledderus JO; Bouten CV; Dankers PY; Verhaar MC
Heart; 2014 Dec; 100(23):1825-30. PubMed ID: 25053725
[TBL] [Abstract][Full Text] [Related]
3. State of the Art: Tissue Engineering in Congenital Heart Surgery.
Boyd R; Parisi F; Kalfa D
Semin Thorac Cardiovasc Surg; 2019; 31(4):807-817. PubMed ID: 31176798
[TBL] [Abstract][Full Text] [Related]
4. Current Challenges and Emergent Technologies for Manufacturing Artificial Right Ventricle to Pulmonary Artery (RV-PA) Cardiac Conduits.
Manavitehrani I; Ebrahimi P; Yang I; Daly S; Schindeler A; Saxena A; Little DG; Fletcher DF; Dehghani F; Winlaw DS
Cardiovasc Eng Technol; 2019 Jun; 10(2):205-215. PubMed ID: 30767113
[TBL] [Abstract][Full Text] [Related]
5. Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity.
Fioretta ES; Motta SE; Lintas V; Loerakker S; Parker KK; Baaijens FPT; Falk V; Hoerstrup SP; Emmert MY
Nat Rev Cardiol; 2021 Feb; 18(2):92-116. PubMed ID: 32908285
[TBL] [Abstract][Full Text] [Related]
6. Computational modeling guides tissue-engineered heart valve design for long-term in vivo performance in a translational sheep model.
Emmert MY; Schmitt BA; Loerakker S; Sanders B; Spriestersbach H; Fioretta ES; Bruder L; Brakmann K; Motta SE; Lintas V; Dijkman PE; Frese L; Berger F; Baaijens FPT; Hoerstrup SP
Sci Transl Med; 2018 May; 10(440):. PubMed ID: 29743347
[TBL] [Abstract][Full Text] [Related]
7. Tissue engineering of heart valves: advances and current challenges.
Mol A; Smits AI; Bouten CV; Baaijens FP
Expert Rev Med Devices; 2009 May; 6(3):259-75. PubMed ID: 19419284
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter valve implantation for right atrium-to-right ventricle conduit obstruction or regurgitation after modified Björk-fontan procedure.
Shah AH; Horlick EM; Eicken A; Asnes JD; Bocks ML; Boudjemline Y; Cabalka AK; Fagan TE; Schubert S; Mahadevan VS; Dvir D; Osten M; McElhinney DB
Catheter Cardiovasc Interv; 2017 Feb; 89(2):298-305. PubMed ID: 27465501
[TBL] [Abstract][Full Text] [Related]
9. [Tissue engineering of heart valves].
Akhyari P; Minol P; Assmann A; Barth M; Kamiya H; Lichtenberg A
Chirurg; 2011 Apr; 82(4):311-8. PubMed ID: 21424291
[TBL] [Abstract][Full Text] [Related]
10. Vascular grafts and valves that animate, made from decellularized biologically-engineered tissue tubes.
Syedain ZH; Maciver R; Tranquillo RT
J Cardiovasc Surg (Torino); 2020 Oct; 61(5):577-585. PubMed ID: 32964902
[TBL] [Abstract][Full Text] [Related]
11. Morphology, Clinicopathologic Correlations, and Mechanisms in Heart Valve Health and Disease.
Schoen FJ
Cardiovasc Eng Technol; 2018 Jun; 9(2):126-140. PubMed ID: 27502286
[TBL] [Abstract][Full Text] [Related]
12. [Heart valve and myocardial tissue engineering].
Cebotari S; Tudorache I; Schilling T; Haverich A
Herz; 2010 Aug; 35(5):334-41. PubMed ID: 20631970
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular tissue engineering: From basic science to clinical application.
Fioretta ES; von Boehmer L; Motta SE; Lintas V; Hoerstrup SP; Emmert MY
Exp Gerontol; 2019 Mar; 117():1-12. PubMed ID: 29604404
[TBL] [Abstract][Full Text] [Related]
14. Development of an Off-the-Shelf Tissue-Engineered Sinus Valve for Transcatheter Pulmonary Valve Replacement: a Proof-of-Concept Study.
Motta SE; Fioretta ES; Dijkman PE; Lintas V; Behr L; Hoerstrup SP; Emmert MY
J Cardiovasc Transl Res; 2018 Jun; 11(3):182-191. PubMed ID: 29560553
[TBL] [Abstract][Full Text] [Related]
15. Bioengineering strategies for polymeric scaffold for tissue engineering an aortic heart valve: an update.
Morsi YS
Int J Artif Organs; 2014 Sep; 37(9):651-67. PubMed ID: 25262629
[TBL] [Abstract][Full Text] [Related]
16. Experience and intermediate-term results using the Contegra heterograft for right ventricular outflow reconstruction in adults.
Niclauss L; Delay D; Hurni M; von Segesser LK
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):667-71. PubMed ID: 19638357
[TBL] [Abstract][Full Text] [Related]
17. Application of tissue-engineering principles toward the development of a semilunar heart valve substitute.
Breuer CK; Mettler BA; Anthony T; Sales VL; Schoen FJ; Mayer JE
Tissue Eng; 2004; 10(11-12):1725-36. PubMed ID: 15684681
[TBL] [Abstract][Full Text] [Related]
18. Decellularization and characterization of camel pericardium as a new scaffold for tissue engineering and regenerative medicine.
Jafari Sorkhdehi MM; Doostmohammadi A; Talebi A; Alizadeh A
Asian Cardiovasc Thorac Ann; 2024 May; 32(4):194-199. PubMed ID: 38767039
[TBL] [Abstract][Full Text] [Related]
19. Off-the-shelf tissue engineered heart valves for in situ regeneration: current state, challenges and future directions.
Motta SE; Lintas V; Fioretta ES; Hoerstrup SP; Emmert MY
Expert Rev Med Devices; 2018 Jan; 15(1):35-45. PubMed ID: 29257706
[TBL] [Abstract][Full Text] [Related]
20. Tissue-engineered heart valve scaffolds.
Dohmen PM; Konertz W
Ann Thorac Cardiovasc Surg; 2009 Dec; 15(6):362-7. PubMed ID: 20081743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
